Recurrent Adult Immunoblastic Large Cell Lymphoma Recruiting Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01760655Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment